Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICN Pharmaceuticals

This article was originally published in The Gray Sheet

Executive Summary

Acquisition of SLS Biophile Ltd. and its laser-based, non-ablative wrinkle reduction technology is announced June 28, expanding the drug firm's dermatological franchise. A March 510(k) application is pending at FDA for Swansea, Wales-based SLS Biophile's N-Lite laser treatment system, which has been available in Europe since early this year as an alternative to chemical-based treatments. Financial terms of the deal were not disclosed
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT013567

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel